E23Q (p.Glu23Gln) variant of NFKBIA (NF-kappa-B inhibitor alpha)
E23Q (p.Glu23Gln) in NFKBIA (NF-kappa-B inhibitor alpha) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; high impact. The record also includes variant effect predictions and structural context.
E23Q (p.Glu23Gln) variant details
- p.Glu23Gln
- NCI-TCGA TCGA novel
- Variant assessed as somatic; high impact.
- Missense
- MetaLR 0.24
- MetaSVM -0.95
- SIFT 0.63
- UniProt: Variant assessed as somatic; high impact.
- Structural context available